Biomedical Scientist graduated from the Hermínio Ometto University Center (FHO/UNIARARAS) with specializations in Molecular Biology and Clinical Analyses (Clinical Pathology). Holds a Master's and Ph.D. in Sciences, specifically in the field of Clinical Medicine, from the postgraduate program in Clinical Medicine at UNICAMP. During her Ph.D., she completed a intership at the Laboratory of Research in Head and Neck Cancer at the Lausanne University Hospital (CHUV) in Switzerland. She was a teacher in the Molecular Biology discipline at the Faculty of Pharmaceutical Sciences of UNESP Araraquara (FCFar). Currently, she is a Collaborating Researcher at the Cancer Genetics Laboratory of UNICAMP, where she is also conducting her Postdoctoral project affiliated with the CancerThera CEPID (FAPESP). She has expertise in the areas of oncology, molecular biology, and cellular assays. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Head and neck cancer (HNC) represents a serious health problem worldwide and is the seventh most common type of cancer. Despite advancements in diagnostic and therapeutic approaches, there has been no substantial increase in the average survival rate of patients with the disease in recent decades. The "Center for Cancer Innovation with Emphasis on Metals and Theranostics" (CancerThera), f…
Glioblastoma multiforme (GBM) is the most aggressive brain tumor, with high morbidity and mortality rates. The treatment for patients with GBM is surgical resection of the tumor followed by temozolomide chemoradiation, but the median overall survival is only 14 months. The epidermal growth factor receptor (EGFR) overexpression in GBM drives cell invasion and tumor progression, but results…
| 2 / 2 | Ongoing scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID